Breaking News
Ad-Free Version. Subscribe now to follow markets, faster and distraction-free. Upgrade now
0
Ad-Free Version. Subscribe now to follow markets, faster and distraction-free. More details
Close

Maybaker (MAYBAKE)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
3.990 0.000    0.00%
26/02 - Closed. Currency in NGN ( Disclaimer )
Type:  Equity
Market:  Nigeria
ISIN:  NGMAYBAKER01 
  • Volume: 148,982
  • Bid/Ask: 3.650 / 3.900
  • Day's Range: 3.990 - 3.990
Maybaker 3.990 0.000 0.00%
IndustryBiotechnology & Drugs
SectorHealthcare
Employees

325

Equity Type

ORD

May & Baker Nigeria Plc is a Nigeria-based company, which is involved in the manufacture, sale and distribution of human pharmaceuticals, human vaccines and consumer products. The Company's operating segments include Pharmaceuticals, Beverage and Foods. Its Pharmaceuticals segment is involved in the production and sale of human pharmaceuticals and human vaccines. Its Beverage segment is involved in the production of beverage drinks, including bottled water. Its Foods segment is involved in the production of package foods, including noodles. The Company offers pharmaceutical products for anti-diabetics, anti-hypertensive, anti-infectives, anti-malaria, analgesic, cough and cold, multivitamin and anxiolytics. Its anti-diabetic's products are sold under Diatab and Diamet brands. Its anti-hypertensive products are sold under Cardovasc Retard and Ramitace brands. Its food products are sold under the Mimee brand. Its beverages sector is engaged in the bottling of Lily brand of table water.

Contact Information

Phone +234-1-2121290
Fax 1-4962832

Top Executives

Name Age Since Title
Daisy Ehanire Danjuma 67 2019 Non-Executive Chairman
Nnamdi N. Okafor - 2011 Managing Director/Chief Executive Officer, Executive Director
Valentine C. Okelu - 2016 Executive Director, Foods Division
Ishaya Dankaro - 2010 Non-Executive Director
Adebayo Adetunji Adeleke - 2010 Non-Executive Director
Gladys N. Umoh - - Head, Human Capital Development
Gloria Ijeoma Odumodu - - Non-Executive Director
Edudie Abebe - 2013 Non-Executive Director
Ayodeji S. Aboderin - 2017 Executive Director, Finance
Chukuka S. Chukutem - 2016 Executive Director, Pharma Sales & Marketing
Yetunde Adigun - - Head, Pharma Plant Operations
Samuel Maduka Onyishi - 2019 Non-Executive Director
Patrick O. Ajah - 2021 Managing Director, Executive Director
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

MAYBAKE Comments

Write your thoughts about Maybaker
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email